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Proper chromosome segregation during mitosis ensures the equal inheritance of parental DNA by two 
daughter cells. Errors in chromosome segregation result in aneuploidy, the inheritance of abnormal 
chromosome numbers. Aneuploidy is a characteristic of tumors cells; therefore, understanding the 
factors that cause chromosome missegregation will provide insight into carcinogenesis. Certain post-
transcriptional histone modifications in centromeric and pericentromeric regions are associated with 
maintaining kinetochore integrity and ensuring proper chromosome segregation. However, whether loss 
or improper distribution of modifications directly or indirectly causes chromosome missegregation is yet 
to be determined. To compare the DNA content of mutated yeast strains relative to WT, FACS analyses 
were conducted to detect cells’ DNA content. Furthermore, as cells with inherent defects in 
chromosome segregation or kinetochore integrity will likely be hypersensitive to benomyl, a 
microtubule depolymerizing agent, relative to WT, benomyl growth assays were conducted. Mutants 
with defects in these assays were assessed for changes in histone composition at CEN3 compared to WT 
by ChIP. FACS analyses indicated that acetylation at H3 and the corresponding acetyltransferase (HAT) 
are necessary for maintaining proper DNA content, consistent with their being required for proper 
chromosome segregation. Furthermore, mutations lacking the catalytic subunit of an H4-specific HAT 
complex were hypersensitive to benomyl, implying the involvement of this HAT in chromosome 
segregation. Together, these findings suggest that defects in acetylation regulation and histone 
deposition may contribute to aneuploidy and identifies potential targets for the development of new 
cancer therapeutics focusing on aneuploidy, but future assays are necessary to provide further insight. 
 
